Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 22Uterine Cervical Neoplasms 18Uterine Cervical Dysplasia 6Condylomata Acuminata 6Anus Neoplasms 5Vulvar Neoplasms 4Vaginal Neoplasms 3HIV Infections 2Whooping Cough 1Virus Diseases 1Tetanus 1Persistent Infection 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Metastasis 1Meningitis 1Lung Neoplasms 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Genital Human Papilloma Virus Infection 1Endometrial Neoplasms 1Diphtheria 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Acquired Immunodeficiency Syndrome 1

Interventions

Vaccines 1Topotecan 1Papillomavirus Vaccines 1Music Therapy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gemcitabine 1Dialectical Behavior Therapy 1Cytarabine 1Cholecalciferol 1Airway Extubation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Meningitis × Papillomavirus Vaccines × Clear all
NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡